Cited by 1,730

The DOI matches its Crossref record; 401 of the 401 references it cites were found in a registry or an index.

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation

Open access

Kamaly, Nazila, Xiao, Zeyu, Valencia, Pedro M., Radovic-Moreno, Aleksandar F., Farokhzad, Omid C.·2012·Chemical Society Reviews

DOI 10.1039/c2cs15344k

Open this paper in CoChat — free account

Abstract

Polymeric materials have been used in a range of pharmaceutical and biotechnology products for more than 40 years. These materials have evolved from their earlier use as biodegradable products such as resorbable sutures, orthopaedic implants, macroscale and microscale drug delivery systems such as microparticles and wafers used as controlled drug release depots, to multifunctional nanoparticles (NPs) capable of targeting, and controlled release of therapeutic and diagnostic agents. These newer generations of targeted and controlled release polymeric NPs are now engineered to navigate the complex in vivo environment, and incorporate functionalities for achieving target specificity, control of drug concentration and exposure kinetics at the tissue, cell, and subcellular levels. Indeed this optimization of drug pharmacology as aided by careful design of multifunctional NPs can lead to improved drug safety and efficacy, and may be complimentary to drug enhancements that are traditionally achieved by medicinal chemistry. In this regard, polymeric NPs have the potential to result in a highly differentiated new class of therapeutics, distinct from the original active drugs used in their composition, and distinct from first generation NPs that largely facilitated drug formulation. A greater flexibility in the design of drug molecules themselves may also be facilitated following their incorporation into NPs, as drug properties (solubility, metabolism, plasma binding, biodistribution, target tissue accumulation) will no longer be constrained to the same extent by drug chemical composition, but also become in-part the function of the physicochemical properties of the NP. The combination of optimally designed drugs with optimally engineered polymeric NPs opens up the possibility of improved clinical outcomes that may not be achievable with the administration of drugs in their conventional form. In this critical review, we aim to provide insights into the design and development of targeted polymeric NPs and to highlight the challenges associated with the engineering of this novel class of therapeutics, including considerations of NP design optimization, development and biophysicochemical properties. Additionally, we highlight some recent examples from the literature, which demonstrate current trends and novel concepts in both the design and utility of targeted polymeric NPs (444 references).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1039/c2cs15344k

Cites

401 of 401 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 201–400 of 401

Efficacy of transferrin‐conjugated paclitaxel‐loaded nanoparticles in a murine model of prostate cancer
Sahoo, S. K., Ma, W., & Labhasetwar, V. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
How can biochemical reactions within cells differ from those in test tubes?
Minton, A. P. (2015) · Journal of Cell Science · doi:10.1242/jcs.170183 · Cited by 320
Development and Brain Delivery of Chitosan−PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26
Aktaş, Y., Yemisci, M., Andrieux, K., Gürsoy, R. N., Alonso, M. J., Fernandez-Megia, E., Novoa-Carballal, R., Quiñoá, E., Riguera, R., Sargon, M. F., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050217o · Cited by 318
Doxorubicin‐Loaded Polymeric Micelle Overcomes Multidrug Resistance of Cancer by Double‐Targeting Folate Receptor and Early Endosomal pH
Kim, D., Lee, E. S., Oh, K. T., Gao, Z. G., & Bae, Y. H. (2008) · Small · doi:10.1002/smll.200701275 · Cited by 313
Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel
Cho, H.-J., Yoon, H. Y., Koo, H., Ko, S.-H., Shim, J.-S., Lee, J.-H., Kim, K., Chan Kwon, I., & Kim, D.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.028 · Cited by 304
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
Valle, J. W., Armstrong, A., Newman, C., Alakhov, V., Pietrzynski, G., Brewer, J., Campbell, S., Corrie, P., Rowinsky, E. K., & Ranson, M. (2011) · Investigational New Drugs · doi:10.1007/s10637-010-9399-1 · Cited by 303
Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(β-amino ester) block copolymer micelles for cancer therapy
Ko, J., Park, K., Kim, Y.-S., Kim, M. S., Han, J. K., Kim, K., Park, R.-W., Kim, I.-S., Song, H. K., Lee, D. S., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.012 · Cited by 302
Responsive Theranostic Systems: Integration of Diagnostic Imaging Agents and Responsive Controlled Release Drug Delivery Carriers
Caldorera-Moore, M. E., Liechty, W. B., & Peppas, N. A. (2011) · Accounts of Chemical Research · doi:10.1021/ar2001777 · Cited by 301
Uptake Mechanism of Oppositely Charged Fluorescent Nanoparticles in HeLa Cells
Dausend, J., Musyanovych, A., Dass, M., Walther, P., Schrezenmeier, H., Landfester, K., & Mailänder, V. (2008) · Macromolecular Bioscience · doi:10.1002/mabi.200800123 · Cited by 297
Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides
Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.031 · Cited by 296
Identifying off-target effects and hidden phenotypes of drugs in human cells
MacDonald, M. L., Lamerdin, J., Owens, S., Keon, B. H., Bilter, G. K., Shang, Z., Huang, Z., Yu, H., Dias, J., Minami, T., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio790 · Cited by 293
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo
Porkka, K., Laakkonen, P., Hoffman, J. A., Bernasconi, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062189599 · Cited by 291
Targeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic Implications
Kaufmann, A. M., & Krise, J. P. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20792 · Cited by 284
Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing Nanoparticles
Bartlett, D. W., & Davis, M. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603539 · Cited by 283
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D., Nam, E. J., Mora, E. M., Stone, R. L., Lu, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 282
Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
Ros, P. R., Freeny, P. C., Harms, S. E., Seltzer, S. E., Davis, P. L., Chan, T. W., Stillman, A. E., Muroff, L. R., Runge, V. M., & Nissenbaum, M. A. (1995) · Radiology · doi:10.1148/radiology.196.2.7617864 · Cited by 278
Distinct Polymer Architecture Mediates Switching of Complement Activation Pathways at the Nanosphere−Serum Interface: Implications for Stealth Nanoparticle Engineering
Hamad, I., Al-Hanbali, O., Hunter, A. C., Rutt, K. J., Andresen, T. L., & Moghimi, S. M. (2010) · ACS Nano · doi:10.1021/nn101990a · Cited by 276
Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles
Dreis, S., Rothweiler, F., Michaelis, M., Cinatl, J., Kreuter, J., & Langer, K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.036 · Cited by 275
In vivo selection of tumor-targeting RNA motifs
Mi, J., Liu, Y., Rabbani, Z. N., Yang, Z., Urban, J. H., Sullenger, B. A., & Clary, B. M. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.277 · Cited by 269
A New Approach to Cancer Chemotherapy: Selective Enhancement of Tumor Blood Flow With Angiotensin II 23
(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.663 · Cited by 268
Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
Murakami, M., Cabral, H., Matsumoto, Y., Wu, S., Kano, M. R., Yamori, T., Nishiyama, N., & Kataoka, K. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001385 · Cited by 262
Self-assembled thermoresponsive micelles of poly(N-isopropylacrylamide-b-methyl methacrylate)
Wei, H., Zhang, X.-Z., Zhou, Y., Cheng, S.-X., & Zhuo, R.-X. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.09.028 · Cited by 259
All-electronic droplet generation on-chip with real-time feedback control for EWOD digital microfluidics
Gong, J., & Kim, C.-J. “. (2008) · Lab on a Chip · doi:10.1039/b717417a · Cited by 258
Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Self-citation
Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process
Hamad, I., Hunter, A. C., Szebeni, J., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.276 · Cited by 253
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Chan, J. M., Zhang, L., Tong, R., Ghosh, D., Gao, W., Liao, G., Yuet, K. P., Gray, D., Rhee, J.-W., Cheng, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914585107 · Cited by 253
Self-citation
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.007 · Cited by 252
Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier
Kim, T. H., Park, I. K., Nah, J. W., Choi, Y. J., & Cho, C. S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.063 · Cited by 250
Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groups
Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 250
Self-citation
Poly(Ethylene Oxide)-Modified Poly(β-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part 2. In Vivo Distribution and Tumor Localization Studies
Shenoy, D., Little, S., Langer, R., & Amiji, M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8343-0 · Cited by 246
Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates
Zhang, X.-X., Eden, H. S., & Chen, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.023 · Cited by 243
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery
Patil, Y. B., Toti, U. S., Khdair, A., Ma, L., & Panyam, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.056 · Cited by 242
Azide: A Unique Dipole for Metal‐Free Bioorthogonal Ligations
Debets, M. F., van der Doelen, C. W. J., Rutjes, F. P. J. T., & van Delft, F. L. (2010) · ChemBioChem · doi:10.1002/cbic.201000064 · Cited by 240
Nanomaterial standards for efficacy and toxicity assessment
Adiseshaiah, P. P., Hall, J. B., & McNeil, S. E. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.66 · Cited by 238
Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains
Silverman, J., Lu, Q., Bakker, A., To, W., Duguay, A., Alba, B. M., Smith, R., Rivas, A., Li, P., Le, H., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1166 · Cited by 237
Antibody Targeting of Liposomes: Cell Specificity Obtained by Conjugation of F(ab′) 2 to Vesicle Surface
Heath, T. D., Fraley, R. T., & Papahdjopoulos, D. (1980) · Science · doi:10.1126/science.7423203 · Cited by 237
Synthesis of Size‐Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single‐Layer Microchannels
Rhee, M., Valencia, P. M., Rodriguez, M. I., Langer, R., Farokhzad, O. C., & Karnik, R. (2011) · Advanced Materials · doi:10.1002/adma.201004333 · Cited by 236
Self-citation
Gold Nanoparticles as a Versatile Platform for Optimizing Physicochemical Parameters for Targeted Drug Delivery
Bergen, J. M., von Recum, H. A., Goodman, T. T., Massey, A. P., & Pun, S. H. (2006) · Macromolecular Bioscience · doi:10.1002/mabi.200600075 · Cited by 225
Folate-decorated nanogels for targeted therapy of ovarian cancer
Nukolova, N. V., Oberoi, H. S., Cohen, S. M., Kabanov, A. V., & Bronich, T. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.006 · Cited by 223
Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models
Schluep, T., Hwang, J., Cheng, J., Heidel, J. D., Bartlett, D. W., Hollister, B., & Davis, M. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1566 · Cited by 222
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes
Balthasar, S., Michaelis, K., Dinauer, N., von Briesen, H., Kreuter, J., & Langer, K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.047 · Cited by 221
A high-throughput label-free nanoparticle analyser
Fraikin, J.-L., Teesalu, T., McKenney, C. M., Ruoslahti, E., & Cleland, A. N. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.24 · Cited by 218
Oxime Linkage: A Robust Tool for the Design of pH-Sensitive Polymeric Drug Carriers
Jin, Y., Song, L., Su, Y., Zhu, L., Pang, Y., Qiu, F., Tong, G., Yan, D., Zhu, B., & Zhu, X. (2011) · Biomacromolecules · doi:10.1021/bm200956u · Cited by 216
Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake
Vonarbourg, A., Passirani, C., Saulnier, P., Simard, P., Leroux, J. C., & Benoit, J. P. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30711 · Cited by 216
In Vitro Extended-Release Properties of Drug-Loaded Poly(DL-Lactic Acid) Nanoparticles Produced by a Salting-Out Procedure
Allémann, E., Leroux, J.-C., Gurny, R., & Doelker, E. (1993) · Pharmaceutical Research · doi:10.1023/a:1018970030327 · Cited by 212
Selection of Tumor-binding Ligands in Cancer Patients with Phage Display Libraries
Krag, D. N., Shukla, G. S., Shen, G.-P., Pero, S., Ashikaga, T., Fuller, S., Weaver, D. L., Burdette-Radoux, S., & Thomas, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4441 · Cited by 212
Surface-Functionalizable Polymer Nanogels with Facile Hydrophobic Guest Encapsulation Capabilities
Ryu, J.-H., Jiwpanich, S., Chacko, R., Bickerton, S., & Thayumanavan, S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102316a · Cited by 211
Facile, Template‐Free Synthesis of Stimuli‐Responsive Polymer Nanocapsules for Targeted Drug Delivery
Kim, E., Kim, D., Jung, H., Lee, J., Paul, S., Selvapalam, N., Yang, Y., Lim, N., Park, C. G., & Kim, K. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000818 · Cited by 209
Tumor-Targeted Gene Delivery Using Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles: In Vitro and in Vivo Studies
Kaul, G., & Amiji, M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-4590-3 · Cited by 204
Binding Affinity and Kinetic Analysis of Targeted Small Molecule-Modified Nanoparticles
Tassa, C., Duffner, J. L., Lewis, T. A., Weissleder, R., Schreiber, S. L., Koehler, A. N., & Shaw, S. Y. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900438a · Cited by 202
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles
Pun, S. H., Tack, F., Bellocq, N. C., Cheng, J., Grubbs, B. H., Jensen, G. S., Davis, M. E., Brewster, M., Janicot, M., Janssens, B., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.7.918 · Cited by 201
High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment.
Willuda, J., Honegger, A., Waibel, R., Schubiger, P. A., Stahel, R. A., Zangemeister‐Wittke, U., & Plückthun, A. (1999) · PubMed · Cited by 200
PLGA Nanoparticle−Peptide Conjugate Effectively Targets Intercellular Cell-Adhesion Molecule-1
Zhang, N., Chittasupho, C., Duangrat, C., Siahaan, T. J., & Berkland, C. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700227z · Cited by 198
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery
Siegwart, D. J., Whitehead, K. A., Nuhn, L., Sahay, G., Cheng, H., Jiang, S., Ma, M., Lytton-Jean, A., Vegas, A., Fenton, P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106379108 · Cited by 198
Design of surface-modified poly(d,l-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone
Choi, S.-W., & Kim, J.-H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.003 · Cited by 196
Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery
Shi, J., Xiao, Z., Votruba, A. R., Vilos, C., & Farokhzad, O. C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101554 · Cited by 196
Self-citation
Synthetic Affibody Molecules: A Novel Class of Affinity Ligands for Molecular Imaging of HER2-Expressing Malignant Tumors
Orlova, A., Tolmachev, V., Pehrson, R., Lindborg, M., Tran, T., Sandström, M., Nilsson, F. Y., Wennborg, A., Abrahmsén, L., & Feldwisch, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2887 · Cited by 193
Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle
Lu, W., Wan, J., She, Z., & Jiang, X. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.015 · Cited by 193
Ethics in Nanomedicine
Resnik, D. B., & Tinkle, S. S. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.345 · Cited by 192
Paclitaxel‐Initiated, Controlled Polymerization of Lactide for the Formulation of Polymeric Nanoparticulate Delivery Vehicles
Tong, R., & Cheng, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800491 · Cited by 190
Overcoming in vivo barriers to targeted nanodelivery
Chrastina, A., Massey, K. A., & Schnitzer, J. E. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.143 · Cited by 189
Extravasation of polymeric nanomedicines across tumor vasculature
Danquah, M. K., Zhang, X. A., & Mahato, R. I. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.005 · Cited by 188
Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles
Valencia, P. M., Hanewich-Hollatz, M. H., Gao, W., Karim, F., Langer, R., Karnik, R., & Farokhzad, O. C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.078 · Cited by 184
Self-citation
Multifunctional nanoarchitectures from DNA-based ABC monomers
Lee, J. B., Roh, Y. H., Um, S. H., Funabashi, H., Cheng, W., Cha, J. J., Kiatwuthinon, P., Muller, D. A., & Luo, D. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.93 · Cited by 182
Elevating Blood Pressure as a Strategy to Increase Tumor-targeted Delivery of Macromolecular Drug SMANCS: Cases of Advanced Solid Tumors
Nagamitsu, A., Greish, K., & Maeda, H. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp074 · Cited by 180
Composite Block Copolymer Stabilized Nanoparticles: Simultaneous Encapsulation of Organic Actives and Inorganic Nanostructures
Gindy, M. E., Panagiotopoulos, A. Z., & Prud'homme, R. K. (2008) · Langmuir · doi:10.1021/la702902b · Cited by 178
Preclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate
Reddy, J. A., Dorton, R., Westrick, E., Dawson, A., Smith, T., Xu, L.-C., Vetzel, M., Kleindl, P., Vlahov, I. R., & Leamon, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0033 · Cited by 176
Cell-specific delivery of genes with glycosylated carriers
HASHIDA, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00209-5 · Cited by 171
CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics
Guo, K.-T., Ziemer, G., Paul, A., & Wendel, H. P. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9040668 · Cited by 169
Physicochemical characteristics of pH-sensitive poly(l-Histidine)-b-poly(ethylene glycol)/poly(l-Lactide)-b-poly(ethylene glycol) mixed micelles
Yin, H., Lee, E. S., Kim, D., Lee, K. H., Oh, K. T., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.014 · Cited by 168
Inhibition of brain tumor growth by intravenous poly(β- l -malic acid) nanobioconjugate with pH-dependent drug release
Ding, H., Inoue, S., Ljubimov, A. V., Patil, R., Portilla-Arias, J., Hu, J., Konda, B., Wawrowsky, K. A., Fujita, M., Karabalin, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003919107 · Cited by 168
Determinants of Paclitaxel Penetration and Accumulation in Human Solid Tumor
Kuh, H.-J., Jang, S. H., Wientjes, M. G., Weaver, J. R., & Au, J. L.-S. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34976-6 · Cited by 167
A Novel Poly(l-glutamic acid) Dendrimer Based Drug Delivery System with Both pH-Sensitive and Targeting Functions
Yuan, H., Luo, K., Lai, Y., Pu, Y., He, B., Wang, G., Wu, Y., & Gu, Z. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1000923 · Cited by 166
HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors
Wang, X., Li, J., Wang, Y., Cho, K. J., Kim, G., Gjyrezi, A., Koenig, L., Giannakakou, P., Shin, H. J. C., Tighiouart, M., et al. (2009) · ACS Nano · doi:10.1021/nn900649v · Cited by 165
HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy
Alexis, F., Basto, P., Levy‐Nissenbaum, E., Radovic‐Moreno, A. F., Zhang, L., Pridgen, E., Wang, A. Z., Marein, S. L., Westerhof, K., Molnar, L. K., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800122 · Cited by 164
Self-citation
Nanoparticulate drug delivery systems for cancer chemotherapy
Saha, R. N., Vasanthakumar, S., Bende, G., & Snehalatha, M. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.510804 · Cited by 163
Tumor Accumulation of NIR Fluorescent PEG–PLA Nanoparticles: Impact of Particle Size and Human Xenograft Tumor Model
Schädlich, A., Caysa, H., Mueller, T., Tenambergen, F., Rose, C., Göpferich, A., Kuntsche, J., & Mäder, K. (2011) · ACS Nano · doi:10.1021/nn2026353 · Cited by 161
Highly Specific Dual Enzyme-Mediated Payload Release from Peptide-Coated Silica Particles
Thornton, P. D., & Heise, A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9094439 · Cited by 160
Potent siRNA Inhibitors of Ribonucleotide Reductase Subunit RRM2 Reduce Cell Proliferation In vitro and In vivo
Heidel, J. D., Liu, J. Y.-C., Yen, Y., Zhou, B., Heale, B. S. E., Rossi, J. J., Bartlett, D. W., & Davis, M. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2218 · Cited by 160
Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion
Gosk, S., Vermehren, C., Storm, G., & Moos, T. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135592.28823.47 · Cited by 160
Self-Assembled Hydrogel Nanoparticles Responsive to Tumor Extracellular pH from Pullulan Derivative/Sulfonamide Conjugate: Characterization, Aggregation, and Adriamycin Release in Vitro
Na, K., & Bae, Y. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1015370532543 · Cited by 158
Targeted Biocompatible Nanoparticles for the Delivery of (−)-Epigallocatechin 3-Gallate to Prostate Cancer Cells
Sanna, V., Pintus, G., Roggio, A. M., Punzoni, S., Posadino, A. M., Arca, A., Marceddu, S., Bandiera, P., Uzzau, S., & Sechi, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013715 · Cited by 157
Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases
Seibel, P., Trappe, J., Villani, G., Klopstock, T., Papa, S., & Reichmann, H. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.1.10 · Cited by 157
Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection
Xiao, Z., Levy‐Nissenbaum, E., Alexis, F., Lupták, A., Teply, B. A., Chan, J. M., Shi, J., Digga, E., Cheng, J. W. M., Langer, R., et al. (2012) · ACS Nano · doi:10.1021/nn204165v · Cited by 157
Self-citation
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome
Negussie, A. H., Miller, J. L., Reddy, G., Drake, S. K., Wood, B. J., & Dreher, M. R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.031 · Cited by 156
Enhanced Release of Small Molecules from Near-Infrared Light Responsive Polymer−Nanorod Composites
Hribar, K. C., Lee, M. H., Lee, D., & Burdick, J. A. (2011) · ACS Nano · doi:10.1021/nn103575a · Cited by 155
Transmembrane passage of hydrophobic compounds through a protein channel wall
Hearn, E. M., Patel, D. R., Lepore, B. W., Indic, M., & van den Berg, B. (2009) · Nature · doi:10.1038/nature07678 · Cited by 153
A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands
Yao, Y., Zhan, X.-Y., Zhang, J., Zou, X., Wang, Z., Xiong, Y., Chen, J., & Chen, G. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.008 · Cited by 153
Aptamers Evolved from Cultured Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient Samples
Shangguan, D., Cao, Z. C., Li, Y., & Tan, W. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.083246 · Cited by 151
Particle size-dependent triggering of accelerated blood clearance phenomenon
Koide, H., Asai, T., Hatanaka, K., Urakami, T., Ishii, T., Kenjo, E., Nishihara, M., Yokoyama, M., Ishida, T., Kiwada, H., et al. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.004 · Cited by 149
Enhanced drug targeting by attachment of an anti αv integrin antibody to doxorubicin loaded human serum albumin nanoparticles
Wagner, S., Rothweiler, F., Anhorn, M. G., Sauer, D., Riemann, I., Weiss, E. C., Katsen‐Globa, A., Michaelis, M., Cinatl, J. J., Schwartz, D., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.093 · Cited by 147
A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model
Wang, X., Li, J., Wang, Y., Koenig, L., Gjyrezi, A., Giannakakou, P., Shin, E. H., Tighiouart, M., Chen, Z. (., Nie, S., et al. (2011) · ACS Nano · doi:10.1021/nn200739q · Cited by 145
Synergistic Targeting of αvβ3 Integrin and Galectin-1 with Heteromultivalent Paramagnetic Liposomes for Combined MR Imaging and Treatment of Angiogenesis
Kluza, E., van der Schaft, D. W. J., Hautvast, P. A. I., Mulder, W. J. M., Mayo, K. H., Griffioen, A. W., Strijkers, G. J., & Nicolay, K. (2009) · Nano Letters · doi:10.1021/nl902659g · Cited by 144
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles
Chan, J. M., Rhee, J., Drum, C. L., Bronson, R. T., Golomb, G., Langer, R., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115945108 · Cited by 143
Self-citation
Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer
Albanell, J., & Baselga, J. M. (1999) · Drugs of today · doi:10.1358/dot.1999.35.12.564040 · Cited by 141
Biodegradable Nanoparticles for Direct or Two-Step Tumor Immunotargeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050137k · Cited by 139
Folate Receptor Targeted Bimodal Liposomes for Tumor Magnetic Resonance Imaging
Kamaly, N., Kalber, T. L., Thanou, M., Bell, J. D., & Miller, A. D. (2009) · Bioconjugate Chemistry · doi:10.1021/bc8002259 · Cited by 139
Self-citation
A low molecular weight PSMA-based fluorescent imaging agent for cancer
Chen, Y., Dhara, S., Banerjee, S. R., Byun, Y., Pullambhatla, M., Mease, R. C., & Pomper, M. G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.017 · Cited by 138
Multifunctional and degradable zwitterionic nanogels for targeted delivery, enhanced MR imaging, reduction-sensitive drug release, and renal clearance
Zhang, L., Xue, H., Cao, Z., Keefe, A. J., Wang, J., & Jiang, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.064 · Cited by 138
A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer
Chang, D.-K., Lin, C., Wu, C., & Wu, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004171 · Cited by 137
Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles
Seow, W. Y., Xue, J. M., & Yang, Y. Y. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.039 · Cited by 132
A Rapid Pathway Toward a Superb Gene Delivery System: Programming Structural and Functional Diversity into a Supramolecular Nanoparticle Library
Wang, H., Liu, K., Chen, K., Lu, Y., Wang, S., Lin, W., Guo, F., Kamei, K., Chen, Y., Ohashi, M., et al. (2010) · ACS Nano · doi:10.1021/nn101908e · Cited by 132
Enhanced Stability of Core−Surface Cross-Linked Micelles Fabricated from Amphiphilic Brush Copolymers
Xu, P., Tang, H., Li, S., Ren, J. T., Kirk, E. V., Murdoch, W. J., Radosz, M., & Shen, Y. (2004) · Biomacromolecules · doi:10.1021/bm049874u · Cited by 132
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy
Basu, S., Harfouche, R., Soni, S., Chimote, G., Mashelkar, R. A., & Sengupta, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902857106 · Cited by 129
Electrostatic Ligand Coatings of Nanoparticles Enable Ligand-Specific Gene Delivery to Human Primary Cells
Green, J. J., Chiu, E., Leshchiner, E. S., Shi, J., Langer, R., & Anderson, D. G. (2007) · Nano Letters · doi:10.1021/nl062395b · Cited by 128
Antibody Targeting of Camptothecin-Loaded PLGA Nanoparticles to Tumor Cells
McCarron, P. A., Marouf, W. M., Quinn, D. J., Fay, F., Burden, R. E., Olwill, S. A., & Scott, C. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800057g · Cited by 127
The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers
Grabnar, P. A., & Kristl, J. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.569763 · Cited by 127
From somatostatin to octreotide LAR: evolution of a somatostatin analogue
Anthony, L. B., & Freda, P. U. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903328959 · Cited by 124
Stimuli-responsive liposome-nanoparticle assemblies
Preiss, M. R., & Bothun, G. D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.584868 · Cited by 121
Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes
Xu, H., Wang, K. Q., Deng, Y. H., & Chen, D. W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.049 · Cited by 120
Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres
Jung, T., Breitenbach, A., & Kissel, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00201-7 · Cited by 120
Dextran based photodegradable hydrogels formed via a Michael addition
Peng, K., Tomatsu, I., van den Broek, B., Cui, C., Korobko, A. V., van Noort, J., Meijer, A. H., Spaink, H. P., & Kros, A. (2011) · Soft Matter · doi:10.1039/c1sm05291h · Cited by 119
Nanomaterials in biological environment: a review of computer modelling studies
Makarucha, A. J., Todorova, N., & Yarovsky, I. (2010) · European Biophysics Journal · doi:10.1007/s00249-010-0651-6 · Cited by 118
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.04.006 · Cited by 117
Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation.
Marco, M. D., Shamsuddin, S., Razak, K. A., Aziz, A. A., Devaux, C., Borghi, E., Lévy, L., & Sadun, C. (2010) · PubMed Central · Cited by 115
Targeting of nanoparticles in cancer
Talekar, M., Kendall, J. D., Denny, W. A., & Garg, S. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834a4554 · Cited by 115
Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems
Weissig, V., & Torchilin, V. P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00131-4 · Cited by 113
Anticancer Drug Delivery with Transferrin Targeted Polymeric Chitosan Vesicles
Dufès, C., Jm, M., Couet, W. R., et al. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012156.65125.01 · Cited by 113
Muromonab CD‐3: A Review of Its Pharmacology, Pharmacokinetics, and Clinical Use in Transplantation
Hooks, M. A., Wade, C. S., & Millikan, W. J. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb03595.x · Cited by 113
Improved therapeutic effect of folate-decorated PLGA–PEG nanoparticles for endometrial carcinoma
Liang, C., Yang, Y., Ling, Y., Huang, Y., Li, T. X., & Li, X. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.016 · Cited by 111
Click Chemistry Functionalized Polymeric Nanoparticles Target Corneal Epithelial Cells through RGD-Cell Surface Receptors
Lu, J., Shi, M., & Shoichet, M. S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8003167 · Cited by 110
A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules
Boddy, A. V., Plummer, E. R., Todd, R., Sludden, J., Griffin, M., Robson, L., Cassidy, J., Bissett, D., Bernareggi, A., Verrill, M. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0803 · Cited by 108
The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer
Campos, S. M., Penson, R. T., Mays, A. R., Berkowitz, R. S., Fuller, A. F., Goodman, A., Matulonis, U. A., Muzikansky, A., & Seiden, M. V. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.5980 · Cited by 107
Morphing Low-Affinity Ligands into High-Avidity Nanoparticles by Thermally Triggered Self-Assembly of a Genetically Encoded Polymer
Simnick, A. J., Valencia, C. A., Liu, R., & Chilkoti, A. (2010) · ACS Nano · doi:10.1021/nn901732h · Cited by 106
F3-Targeted Cisplatin-Hydrogel Nanoparticles as an Effective Therapeutic That Targets Both Murine and Human Ovarian Tumor Endothelial Cells In vivo
Winer, I. S., Wang, S., Lee, Y.-E. K., Fan, W., Gong, Y., Burgos-Ojeda, D., Spahlinger, G., Kopelman, R., & Buckanovich, R. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1917 · Cited by 102
Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer
Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024075 · Cited by 102
High-loading nanosized micelles of copoly(styrene–maleic acid)–zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor
Iyer, A. K., Greish, K. F., Fang, J. Q., Murakami, R., & Maeda, H. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.051 · Cited by 101
Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons
Townsend, S. A., Evrony, G. D., Gu, F., Schulz, M. P., Brown, R. H., & Langer, R. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.011 · Cited by 101
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery Across The Blood–Brain Barrier
Tosi, G., Fano, R. A., Bondioli, L., Badiali, L., Benassi, R., Rivasi, F., Ruozi, B., Forni, F., & Vandelli, M. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.11 · Cited by 100
Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1
Fakhari, A., Baoum, A. A., Siahaan, T. J., Le, K. B., & Berkland, C. J. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22342 · Cited by 97
Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA
Tagami, T., Uehara, Y., Moriyoshi, N., Ishida, T., & Kiwada, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.013 · Cited by 95
Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
Sugano, M., Egilmez, N. K., Yokota, S. J., Chen, F.-A., Harding, J., Huang, S. K., & Bankert, R. B. (2000) · PubMed · Cited by 93
Implantable controlled release systems
Langer, R. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90066-9 · Cited by 93
Mapping Tumor Epitope Space by Direct Selection of Single-Chain Fv Antibody Libraries on Prostate Cancer Cells
Liu, B., Conrad, F., Cooperberg, M. R., Kirpotin, D. B., & Marks, J. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2732 · Cited by 93
Nanoparticles and nanocapsules--new dosage forms in the nanometer size range.
Kreuter, J. (1978) · PubMed · Cited by 93
Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
Elsässer‐Beile, U., Bühler, P., & Wolf, P. (2009) · Current Drug Targets · doi:10.2174/138945009787354601 · Cited by 91
Immunoliposomes and PEGylated Immunoliposomes: Possible Use for Targeted Delivery of Imaging Agents
Torchilin, V. P. (1994) · ImmunoMethods · doi:10.1006/immu.1994.1027 · Cited by 89
Polymer–Drug Conjugates for Novel Molecular Targets
Sanchis, J., Canal, F., Lucas-Domínguez, R., & Vicent, M. J. (2010) · Nanomedicine · doi:10.2217/nnm.10.71 · Cited by 89
Drug targeting to specific vascular sites
Ruoslahti, E. I. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02501-1 · Cited by 89
Immunopharmacotherapy: Vaccination strategies as a treatment for drug abuse and dependence
Moreno, A. Y., & Janda, K. D. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.01.015 · Cited by 86
A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin
Sankhala, K. K., Mita, A. C., Adinin, R., Wood, L. M., Beeram, M., Bullock, S., Yamagata, N., Matsuno, K., Fujisawa, T., & Phan, A. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.2535 · Cited by 84
Preclinical pharmacology of docetaxel
Bissery, M.-C. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00357-o · Cited by 83
Nanoparticle Design Optimization for Enhanced Targeting: Monte Carlo Simulations
Wang, S., & Dormidontova, E. E. (2010) · Biomacromolecules · doi:10.1021/bm100248e · Cited by 83
In Vitro Release Kinetic Pattern of Indomethacin from Poly(D,L-Lactide) Nanocapsules
Ammoury, N., Fessi, H., Devissaguet, J. P., Puisieux, F., & Benita, S. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790902 · Cited by 80
Nanotechnology for drug delivery: the perfect partnership
Farokhzad, O. C. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.9.927 · Cited by 79
Self-citation
Dendrimer−Epidermal Growth Factor Conjugate Displays Superagonist Activity
Thomas, T. P., Shukla, R., Kotlyar, A., Liang, B., Ye, J. Y., Norris, T. B., & Baker, J. R. (2008) · Biomacromolecules · doi:10.1021/bm701185p · Cited by 79
Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon
Chen, D., Shen, Y., Liu, Mu, M., Liang, L., Wang, & Sun (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24344 · Cited by 78
Paclitaxel-Loaded Poly(γ-glutamic acid)-poly(lactide) Nanoparticles as a Targeted Drug Delivery System against Cultured HepG2 Cells
Liang, H., Chen, S.-C., Chen, M., Lee, P.-W., Chen, C.-T., & Sung, H. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0502107 · Cited by 78
Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance
Kaminskas, L. M., McLeod, V. M., Porter, C. J. H., & Boyd, B. J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22682 · Cited by 76
Functional polymers as therapeutic agents: Concept to market place
Dhal, P. K., Polomoscanik, S. C., Avila, L. Z., Holmes-Farley, S. R., & Miller, R. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.004 · Cited by 76
Thermodynamic limits on drug loading in nanoparticle cores
Kumar, V., & Prud’homme, R. K. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21342 · Cited by 76
Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma
Toma, A., Otsuji, E., Kuriu, Y., Okamoto, K. K., Ichikawa, D., Hagiwara, A., Ito, H., Nishimura, T., & Yamagishi, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602668 · Cited by 75
Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA)
Chandran, S. S., Banerjee, S. R., Mease, R. C., Pomper, M. G., & Denmeade, S. R. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5968 · Cited by 74
Antitumor effect of MCC‐465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts
Hamaguchi, T., Matsumura, Y., Nakanishi, Y., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Niki, H., Hosokawa, S., Tagawa, T., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02495.x · Cited by 74
Probing Intracellular Biomarkers and Mediators of Cell Activation Using Nanosensors and Bioorthogonal Chemistry
Haun, J. B., Devaraj, N. K., Marinelli, B. S., Lee, H., & Weissleder, R. (2011) · ACS Nano · doi:10.1021/nn200333m · Cited by 72
Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies
Lin, S. H., & Kleinberg, L. R. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.3.343 · Cited by 72
Immunoliposomes Directed Toward VCAM-1 Interact Specifically with Activated Endothelial Cells—A Potential Tool for Specific Drug Delivery
Voinea, M., Mânduțeanu, I., Butoi, E. D., et al. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7247-3 · Cited by 72
Albumin-Bound Paclitaxel: The Benefit of This New Formulation in the Treatment of Various Cancers
Montana, M., Castera‐Ducros, C., Verhaeghe, P., Terme, T., Vanelle, P., & Rathelot, P. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.2.59 · Cited by 72
Identification of Peptide Ligands for Targeting to the Blood-Brain Barrier
van Rooy, I., Cakir-Tascioglu, S., Couraud, P., Romero, I. A., Weksler, B. B., Storm, G., Hennink, W. E., Schiffelers, R. M., & Mastrobattista, E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0053-6 · Cited by 71
Radiopeptide Imaging and Therapy in the United States
Graham, M. M., & Menda, Y. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085746 · Cited by 71
Destination ‘Lysosome’: a target organelle for tumour cell killing?
Castino, R., Démoz, M., & Isidoro, C. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.643 · Cited by 71
Selection of Smart Small-Molecule Ligands: The Proof of Principle
Drabovich, A. P., Berezovski, M. V., Musheev, M. U., & Krylov, S. N. (2008) · Analytical Chemistry · doi:10.1021/ac8023813 · Cited by 70
Nanoscale Engineering of Biomaterial Surfaces
Lipski, A. M., Jaquiéry, C., Choi, H. S., Eberli, D., Stevens, M. M., Martín, I., Chen, I., & Shastri, V. P. (2007) · Advanced Materials · doi:10.1002/adma.200502617 · Cited by 69
Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers
Cho, C.-S., Kobayashi, A., Takei, R., Ishihara, T., Maruyama, A., & Akaike, T. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00143-5 · Cited by 69
Liposome‐enhanced MRI of neointimal lesions in the ApoE‐KO mouse
Mulder, W. J. M., Douma, K., Koning, G. A., van Zandvoort, M. A. M. J., Lutgens, E., Daemen, M. J. A. P., Nicolay, K., & Strijkers, G. J. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20883 · Cited by 67
Polymalic Acid–Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting both HER2/neu Receptor Synthesis and Activity
Inoue, S., Ding, H., Portilla‐Arias, J., Hu, J., Konda, B. M., Fujita, M., Espinoza, A., Suhane, S., Riley, M., Gates, M. J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3093 · Cited by 67
Active Tumor Targeting of Nanomaterials Using Folic Acid, Transferrin and Integrin Receptors
Kolhatkar, R. B., Lote, A. R., & Khambhati, H. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799044 · Cited by 63
Chemoselective Ligation in the Functionalization of Polysaccharide-Based Particles
Beaudette, T. T., Cohen, J. A., Bachelder, E. M., Broaders, K. E., Cohen, J. L., Engleman, E. G., & Fréchet, J. M. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903984s · Cited by 62
Paclitaxel poliglumex for ovarian cancer
Galic, V., Wright, J. D., Lewin, S. N., & Herzog, T. J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.576666 · Cited by 60
Preclinical safety testing of biotechnology-derived pharmaceuticals
Brennan, F., Shaw, L., Wing, M., & Robinson, C. (2004) · Molecular Biotechnology · doi:10.1385/mb:27:1:59 · Cited by 58
Mitochondrial-Targeted Drug and DNA Delivery
Weissig, V. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i1.10 · Cited by 57
Identification of nose-to-brain homing peptide through phage display
Wan, X.-M., Chen, Y., Xu, W., Yang, W., & Wen, L. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.026 · Cited by 56
Construction and application of pH-triggered cleavable hyperbranched polyacylhydrazone for drug delivery
Zhu, L., Tu, C., Zhu, B., Su, Y., Pang, Y., Yan, D., Wu, J., & Zhu, X. (2011) · Polymer Chemistry · doi:10.1039/c1py00161b · Cited by 56
Aptamer-Modified Nanodrug Delivery Systems
Wu, Z., Tang, L., Zhang, X., Jiang, J., & Tan, W. (2011) · ACS Nano · doi:10.1021/nn2037384 · Cited by 53
Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer
Laginha, K. M., Moase, E. H., Yu, N. Y., Huang, A., & Allen, T. M. (2008) · Journal of drug targeting · doi:10.1080/10611860802229978 · Cited by 53
Targeting of Epidermal Growth Factor Receptor (EGFR)-Expressing Tumor Cells with Sterically Stabilized Affibody Liposomes (SAL)
Beuttler, J., Rothdiener, M., Müller, D., Frejd, F. Y., & Kontermann, R. E. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900061v · Cited by 53
Identification of cancer targets and therapeutics using phage display.
Brissette, R. E., Prendergast, J. K. A., & Goldstein, N. I. (2006) · PubMed · Cited by 53
Accelerated Blood Clearance Was Not Induced for a Gadolinium-Containing PEG-poly(L-lysine)-Based Polymeric Micelle in Mice
Ma, H., Shiraishi, K., Minowa, T., Kawano, K., Yokoyama, M., Hattori, Y., & Maitani, Y. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-0018-9 · Cited by 51
Targeted drug delivery to mammalian mitochondria in living cells
Weissig, V. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.89 · Cited by 50
Targeting the Role of the Endosome in the Pathophysiology of Alzheimer's Disease: A Strategy for Treatment
Tate, B. A., & Mathews, P. M. (2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.10.re2 · Cited by 48
Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release andin vitroantimicrobial activity
Fattal, E., Rojas, J., Roblot-Treupel, L., Andremont, A., & Couvreur, P. (1991) · Journal of Microencapsulation · doi:10.3109/02652049109021855 · Cited by 44
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen
Slovin, S. F. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.561 · Cited by 44
A multi-center, late phase II clinical trial of Genexol® (paclitaxel) and cisplatin for patients with advanced gastric cancer
Park, S., Oh, D., Kim, D., Kim, T., Heo, D. S., Bang, Y., Kim, N. K., Kang, W. K., Kim, H., Im, S., et al. (2004) · Oncology Reports · doi:10.3892/or.12.5.1059 · Cited by 43
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
Loomis, K. H., Smith, B. J., Feng, Y., Garg, H., Yavlovich, A., Campbell-Massa, R., Dimitrov, D. S., Blumenthal, R. P., Xiao, X., & Puri, A. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.01.006 · Cited by 43
Attempted targeting of a monoclonal antibody in a human tumour xenograft system
Warenius, H. M., Galfré, G., Bleehen, N. M., & Milstein, C. (1981) · European Journal of Cancer and Clinical Oncology · doi:10.1016/s0277-5379(81)80006-5 · Cited by 42
Mitochondria-Specific Nanotechnology
Weissig, V., Boddapati, S. V., Jabr, L., & D’Souza, G. G. M. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.275 · Cited by 42
Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort
Crawford, E. D. (2011) · Cancer Management and Research · doi:10.2147/cmar.s12700 · Cited by 42
Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts
Horton, J. K., Houghton, P. J., & Houghton, J. A. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90085-8 · Cited by 40
Selectins Ligand Decorated Drug Carriers for Activated Endothelial Cell Targeting
Banquy, X., Leclair, G., Rabanel, J., Argaw, A., Bouchard, J., Hildgen, P., & Giasson, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800257m · Cited by 40
Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
Sanfilippo, N. J., & Sethi (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s4885 · Cited by 39
Phase-shift, stimuli-responsive Drug Carriers for Targeted Delivery
O’Neill, B. E., & Rapoport, N. Y. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.81 · Cited by 38
Diblock Copolymer Micellar Nanoparticles Decorated with Annexin-A5 Proteins
Schmidt, V., Giacomelli, C., Lecolley, F., Lai‐Kee‐Him, J., Brisson, A. R., & Borsali, R. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062408n · Cited by 29
Accelerated Blood Clearance (ABC) Phenomenon Induced by Administration of PEGylated Liposome
Ishida, T., & Kiwada, H. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.233 · Cited by 28
The use of RGDGWK-lipopeptide to selectively deliver genes to mouse tumor vasculature and its complexation with p53 to inhibit tumor growth
Samanta, S., Sistla, R., & Chaudhuri, A. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.027 · Cited by 27
Surface Modification of Polymeric Micelles by Strain‐Promoted Alkyne–Azide Cycloadditions
Guo, J., Chen, G., Ning, X., Wolfert, M. A., Li, X., Xu, B., & Boons, G. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201002532 · Cited by 25
Active-Targeted Nanotherapy Strategies for Prostate Cancer
Katsogiannou, M., Peng, L., Catapano, C. V., & Rocchi, P. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911797264770 · Cited by 23
Organelle-specific targeting in drug delivery and design☆
Lim, C. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.001 · Cited by 20
Glycosylated carriers for cell-selective and nuclear delivery of nucleic acids
Wijagkanalan, W. (2011) · Frontiers in bioscience · doi:10.2741/3892 · Cited by 17

Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
Zhang, X.-F., Liu, Z.-G., Shen, W., & Gurunathan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091534 · Cited by 3,220
Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Self-citation
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901

See all 1,730

Authors: Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C.
Venue: Chemical Society Reviews
Publisher: Royal Society of Chemistry (RSC)
Published: 2012
Volume: 41
Issue: 7
Pages: 2971
ISSN: 0306-0012 (ISSN-L)
1460-4744
DOI: 10.1039/c2cs15344k
OpenAlex: W2127410754
Cited by: 1,730
References: 401
FWCI: 5.89
Type: journal article
Language: en
Open access: green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources